Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Another may develop significant nausea
The treatment guidelines are evolving based on clinical trial outcomes, shaping the management of metabolic and cardiovascular diseases
Clinical vigilance is particularly important during the initial weeks of therapy and following dose increases
Phase III will enroll 320 patients across 47 sites in China, tracking FVC decline over 52 weeks
US$ 26.09
US$ 20.83
US$ 26.70
US$ 24.01
US$ 20.93
US$ 29.42
US$ 22.34
US$ 21.57
US$ 21.82
